Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
US widens lead over Europe in critical minerals race: WSJ

US widens lead over Europe in critical minerals race: WSJ

Mining.comMining.com2026/07/17 20:03
By:Mining.com

The United States is outspending Europe in the race to secure critical minerals outside China, raising concerns that European manufacturers could remain dependent on Chinese supplies, The Wall Street Journal reported late Thursday.

var rnd = window.rnd || Math.floor(Math.random() * 10e6); var pid472436 = window.pid472436 || rnd; var plc472436 = window.plc472436 || 0; var abkw = window.abkw || ''; var absrc = 'https://servedbyadbutler.com/adserve/;ID=181210;size=0x0;setID=472436;type=js;sw=' + screen.width + ';sh=' + screen.height + ';spr=' + window.devicePixelRatio + ';kw=' + abkw + ';pid=' + pid472436+ ';place=' + (plc472436++) + ';rnd=' + rnd + ';click=CLICK_MACRO_PLACEHOLDER'; document.write('
');

Washington has committed about $46 billion to critical raw materials projects over the past five years through grants, loans and tax incentives – roughly eight times the amount allocated by the European Union, citing an analysis by the French Institute of International Relations.

The US has also negotiated preferential access to mineral resources in countries including the Democratic Republic of Congo and Ukraine while backing overseas projects through financing programs.

Disruption

The aggressive US strategy has already disrupted European efforts, the Journal said. London-based rare earth developer Pensana (LON: PRE), which is developing the Longonjo project in Angola, shifted plans for a processing plant from Britain to the US to pursue Export-Import Bank financing.

Privately held Brazilian rare earth producer Serra Verde, which operates a rare earth mine in Goiás state, secured US government-backed financing and later agreed to sell its magnetic rare earth production under a long-term arrangement supported by Washington.

European industry leaders told the newspaper they fear the US could dominate emerging non-Chinese supply chains. Pensana founder Paul Atherley described it as like friendly fire to other Western countries.

The European Union is responding with plans for a €3-billion ($3.4billion) financing hub, strategic stockpiles and partnerships with countries including Canada, Argentina, Norway and South Africa. By 2030, the bloc aims to ensure that no single country supplies more than 65% of its strategic raw material needs, the Journal reported.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"

Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.

华尔街见闻•2026/09/29 01:01

Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business

Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.

华尔街见闻•2026/09/29 00:51

AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose

This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.

华尔街见闻•2026/09/29 00:26